ISO 13485 implementation is widely recognized as a prestigious and trusted stamp of quality throughout the MedTech industry. It is associated with improved efficiencies, speed and consistency of service and operations – and higher customer satisfaction.

ISAB is now upgrading its Quality Management System (QMS) and is implementing EN ISO 13485 in the company. The new QMS is expected to deliver benefits in ISAB’s current preclinical work, and to lay a robust foundation, together with the recently performed clinical study performed on the flagship system PreciseInhale®.

CEO Manoush Masarrat: "This is a valuable and natural step forward for us and our customers. It will benefit and refine our processes in our current and future settings. ISAB has always been totally committed to delivering a standard of excellence and precision to its customers that enables them to effectively de-risk their research and development work. This upgrade is a natural extension of that."

For more information on Inhalation Sciences, please contact:

Manoush Masarrat, CEO

E-mail: Manoush.masarrat@inhalation.se

Mobile: +46 (0)73 628 9153

About Inhalations Sciences Sweden AB (publ)

Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments and services for research into inhalation. The company’s patented lab instruments PreciseInhale^® and DissolvIt^® enable researchers in the pharma industry to make drug pipeline decisions at an early stage, saving time and resources for R&D departments, and enables researchers in academic institutions to define how aerosols and small particles impact our lungs, and so our health, when being inhaled.